Objectives:

1. Understand molecular mechanisms of heart failure.

2. Learn about novel gene therapy tools for the treatment of heart failure.

3. Genome editing tools to correct mutations of CV diseases.

 

Session date: 
Friday, December 9, 2016 - 12:00pm to 1:00pm
Speaker Name: 
Roger J. Hajjar, M.D.
Location: 
UCMC W-632
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.